Verona Pharma plc ( NASDAQ:VRNA ) is possibly approaching a major achievement in its business, so we would like ...
Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...
Roth MKM analyst Boobalan Pachaiyappan initiated coverage of Verona Pharma (VRNA) with a Buy rating and $68 price target The firm says its ...
Zacks.com on MSN13h
Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?Verona Pharma PLC American Depositary Share (VRNA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings ...
Calling people "mentally ill" based on their sexual identity and referring to women as "household objects" will now be allowed in the context of political discussions on social media giant Meta's ...
Here are the key developments on the 1,051st day of Russia’s full-scale invasion of Ukraine. European champions Real Madrid crush Mallorca 3-0 and will now play archrival Barcelona in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback